Literature DB >> 24694122

Measurements and simulations of focused beam for orthovoltage therapy.

Hassan Abbas1, Dip N Mahato2, Jahangir Satti3, C A MacDonald4.   

Abstract

PURPOSE: Megavoltage photon beams are typically used for therapy because of their skin-sparing effect. However, a focused low-energy x-ray beam would also be skin sparing, and would have a higher dose concentration at the focal spot. Such a beam can be produced with polycapillary optics. MCNP5 was used to model dose profiles for a scanned focused beam, using measured beam parameters. The potential of low energy focused x-ray beams for radiation therapy was assessed.
METHODS: A polycapillary optic was used to focus the x-ray beam from a tungsten source. The optic was characterized and measurements were performed at 50 kV. PMMA blocks of varying thicknesses were placed between optic and the focal spot to observe any variation in the focusing of the beam after passing through the tissue-equivalent material. The measured energy spectrum was used to model the focused beam in MCNP5. A source card (SDEF) in MCNP5 was used to simulate the converging x-ray beam. Dose calculations were performed inside a breast tissue phantom.
RESULTS: The measured focal spot size for the polycapillary optic was 0.2 mm with a depth of field of 5 mm. The measured focal spot remained unchanged through 40 mm of phantom thickness. The calculated depth dose curve inside the breast tissue showed a dose peak several centimeters below the skin with a sharp dose fall off around the focus. The percent dose falls below 10% within 5 mm of the focus. It was shown that rotating the optic during scanning would preserve the skin-sparing effect of the focused beam.
CONCLUSIONS: Low energy focused x-ray beams could be used to irradiate tumors inside soft tissue within 5 cm of the surface.
© 2014 American Association of Physicists in Medicine.

Entities:  

Mesh:

Year:  2014        PMID: 24694122      PMCID: PMC3978206          DOI: 10.1118/1.4866224

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  7 in total

1.  Beam collimation with polycapillary x-ray optics for high contrast high resolution monochromatic imaging.

Authors:  Francisca R Sugiro; Danhong Li; C A MacDonald
Journal:  Med Phys       Date:  2004-12       Impact factor: 4.071

2.  Xoft Axxent electronic brachytherapy.

Authors:  Adam Dickler; Kambiz Dowlatshahi
Journal:  Expert Rev Med Devices       Date:  2009-01       Impact factor: 3.166

3.  Microscintigraphy with high resolution collimators and radiographic detectors.

Authors:  N Mail; C A MacDonald; W M Gibson
Journal:  Med Phys       Date:  2009-02       Impact factor: 4.071

4.  Photoelectric-enhanced radiation therapy with quasi-monochromatic computed tomography.

Authors:  Gregor Jost; Tristan Mensing; Sven Golfier; Rüdiger Lawaczeck; Hubertus Pietsch; Joachim Hütter; Levent Cibik; Martin Gerlach; Michael Krumrey; Daniel Fratzscher; Vladimir Arkadiev; Reiner Wedell; Michael Haschke; Norbert Langhoff; Peter Wust; Lutz Lüdemann
Journal:  Med Phys       Date:  2009-06       Impact factor: 4.071

5.  Performance of glass fiber antiscatter devices at mammographic energies.

Authors:  R Fahrig; J G Mainprize; N Robert; A Rogers; M J Yaffe
Journal:  Med Phys       Date:  1994-08       Impact factor: 4.071

6.  Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer.

Authors:  David E Wazer; Lisa Berle; Roger Graham; Maureen Chung; Janice Rothschild; Theresa Graves; Blake Cady; Kenneth Ulin; Robin Ruthazer; Thomas A DiPetrillo
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-07-15       Impact factor: 7.038

7.  MammoSite and interstitial brachytherapy for accelerated partial breast irradiation: factors that affect toxicity and cosmesis.

Authors:  Neenad M Shah; Todd Tenenholz; Douglas Arthur; Thomas DiPetrillo; Bruce Bornstein; Gene Cardarelli; Zhen Zheng; Mark J Rivard; Seth Kaufman; David E Wazer
Journal:  Cancer       Date:  2004-08-15       Impact factor: 6.860

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.